High-Dose-Rate Intracavitary Brachytherapy Boost for Early T Stage Nasopharyngeal Carcinoma{PRIVATE}

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 2, 2008, Pages 361-367

  Leung, To Wai ^a   Wong, Victy Y W ^b   Sze, Wing Kin ^b   Lui, Collin M M ^b   Tung, Stewart Y ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

High dose rate; Intracavitary brachytherapy; Nasopharyngeal carcinoma; Routine boost

Indexed keywords

DISEASE CONTROL; RADIOTHERAPY; TUMORS;

INTRACAVITARY BRACHYTHERAPY; ROUTINE BOOST;

DRUG DOSAGE;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

BRACHYTHERAPY; CARCINOMA; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 38149122291     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.078     Document Type: Article

References (27)

1. Wang C.C. Improved local control of nasopharyngeal carcinoma after intracavitary brachytherapy boost. Am J Clin Oncol 14 (1991) 5-8
2. In: Sobin L.H., and Wittekind C. (Eds). International Union Against Cancer (UICC): TNM classification of malignant tumors. 5th ed. (1997), John Wiley & Sons, New York
3. Levendag P.C., Lagerwaard F.J., Noever I., et al. Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx. Int J Radiat Oncol Biol Phys 52 (2002) 755-768
4. Teo P.M., Leung S.F., Lee W.Y., et al. Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma-the existence of a dose-tumor-control relationship above conventional tumoricidal dose. Int J Radiat Oncol Biol Phys 46 (2000) 445-458
5. Leung T.W., Tung S.Y., Sze W.K., et al. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 47 (2000) 405-412
6. Ho J.H. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 4 (1978) 183-198
7. Leung T.W., Wong V.Y., Tung S.Y., et al. The importance of three-dimensional brachytherapy treatment planning for nasopharyngeal carcinoma. Clin Oncol 9 (1997) 35-40
8. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
9. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35 (1977) 1-39
10. Li X.A., Yu C., and Holmes T. A systemic evaluation of air cavity dose perturbation in megavoltage x-ray beams. Med Phys 27 (2000) 1011-1017
11. Kan W.K., Wu P.M., Leung H.T., et al. The effect of the nasopharyngeal air cavity on x-ray interface doses. Phys Med Biol 43 (1998) 529-537
12. Linthout N., Verellen D., Van Acker S., et al. Evaluation of dose calculation algorithms for dynamic arc treatments of head and neck tumors. Radiother Oncol 64 (2002) 85-95
13. Chang J.T., See L.C., Tang S.G., et al. The role of brachytherapy in early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 36 (1996) 1019-1024
14. Lu J.J., Shakespeare T.P., Tan L.K., et al. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in T1 and T2 nasopharyngeal carcinoma. Head Neck 26 (2004) 389-395
15. Lee N., Hoffman R., Phillips T.L., et al. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: One institution's 45 years experience. Brachytherapy 1 (2002) 74-82
16. Ng T., Richards G.M., Emery R.S., et al. Customized conformal high-dose-rate brachytherapy boost for limited-volume nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 61 (2005) 745-761
17. Ozyar E., Yildz F., Akyol F.H., et al. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 52 (2002) 101-108
18. Syed A.M., Puthawala A.A., Damore S.J., et al. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 year's experience at Long Beach Memorial. Int J Radiat Oncol Biol Phys 47 (2000) 1311-1321
19. Vikram B. Permanent iodine-125 boost after teletherapy in primary cancers of the nasopharynx is safe and highly effective: Long-term results. Int J Radiat Oncol Biol Phys 38 (1997) 1140
20. Leung T.W., Tung S.Y., Wong V.Y., et al. Nasopharyngeal intracavitary brachytherapy: The controversy of T2b disease. Cancer 104 (2005) 1648-1655
21. Leung T.W., Tung S.Y., Sze W.K., et al. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48 (2000) 1331-1338
22. Teo P.M., Kwan W.H., Chan A.T., et al. How successful is high-dose (≤ 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?. Int J Radiat Oncol Biol Phys 40 (1998) 897-913
23. Lee A.W., Foo W., Law S.C., et al. Reirradiation for recurrent nasopharyngeal carcinoma: Factors affecting the therapeutic ratio and ways for improvement. Int J Radiat Oncol Biol Phys 38 (1997) 43-52
24. Chua D.T., Sham J.S., Kwong D.L., et al. Locally recurrent nasopharyngeal carcinoma: Treatment results for patients with computed tomography assessment. Int J Radiat Oncol Biol Phys 41 (1998) 379-386
25. Kwong D.L., Sham J.S., and Choy D. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patients. Int J Radiat Oncol Biol Phys 30 (1994) 1029-1036
26. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
27. Wolden S.L., Chen W.C., Pfister D.G., et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 64 (2006) 57-62